{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T21:58:17Z","timestamp":1793656697485,"version":"4.5.1"},"reference-count":29,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T00:00:00Z","timestamp":1761782400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UL1TR002319"],"award-info":[{"award-number":["UL1TR002319"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UM1AI109568"],"award-info":[{"award-number":["UM1AI109568"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["OT2HL161847"],"award-info":[{"award-number":["OT2HL161847"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["OT2OD032581"],"award-info":[{"award-number":["OT2OD032581"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U01DK100846"],"award-info":[{"award-number":["U01DK100846"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U54DK083912"],"award-info":[{"award-number":["U54DK083912"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U2CDK114886"],"award-info":[{"award-number":["U2CDK114886"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01MD014712"],"award-info":[{"award-number":["R01MD014712"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004191","name":"Novo Nordisk AS","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004191","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000862","name":"Doris Duke Charitable Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000862","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009881","name":"Juvenile Diabetes Research Foundation Canada","doi-asserted-by":"publisher","award":["3-SRA-2022-1243-M-B"],"award-info":[{"award-number":["3-SRA-2022-1243-M-B"]}],"id":[{"id":"10.13039\/100009881","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009881","name":"Juvenile Diabetes Research Foundation Canada","doi-asserted-by":"publisher","award":["3-SRA-2023-1373-M-B"],"award-info":[{"award-number":["3-SRA-2023-1373-M-B"]}],"id":[{"id":"10.13039\/100009881","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004326","name":"Bayer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004326","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["kidney-international.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.kint.2025.10.005","type":"journal-article","created":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T23:50:48Z","timestamp":1762559448000},"page":"6-16","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["REMODELing mechanistic trials for kidney disease: a multimodal, tissue-centered approach to understand the renal mechanism of action of semaglutide"],"prefix":"10.1016","volume":"109","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1027-1851","authenticated-orcid":false,"given":"Menno","family":"Pruijm","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Belmar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petter","family":"Bjornstad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David Z.I.","family":"Cherney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivek","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Gunnarsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey B.","family":"Hodgin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip A.","family":"Schytz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2235-0103","authenticated-orcid":false,"given":"Katherine R.","family":"Tuttle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4064-0582","authenticated-orcid":false,"given":"Matthias","family":"Kretzler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.kint.2025.10.005_bib1","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/s41581-020-0268-7","article-title":"The impact of chronic kidney disease on global health","volume":"16","author":"Carney","year":"2020","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.kint.2025.10.005_bib2","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.2215\/CJN.11491116","article-title":"Diabetic kidney disease: challenges, progress, and possibilities","volume":"12","author":"Alicic","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2025.10.005_bib3","doi-asserted-by":"crossref","first-page":"S239","DOI":"10.2337\/dc25-S011","article-title":"Chronic kidney disease and risk management: standards of care in diabetes-2025","volume":"48","year":"2025","journal-title":"Diabetes Care"},{"key":"10.1016\/j.kint.2025.10.005_bib4","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/nrneph.2017.123","article-title":"GLP-1 and the kidney: from physiology to pharmacology and outcomes in diabetes","volume":"13","author":"Muskiet","year":"2017","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.kint.2025.10.005_bib5","doi-asserted-by":"crossref","first-page":"F443","DOI":"10.1152\/ajprenal.00280.2019","article-title":"Glucagon-like peptide-1 receptors in the kidney: impact on renal autoregulation","volume":"318","author":"Hviid","year":"2020","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.kint.2025.10.005_bib6","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.kint.2023.09.029","article-title":"Glucagon-like peptide-1 receptor signaling modifies the extent of diabetic kidney disease through dampening the receptor for advanced glycation end products-induced inflammation","volume":"105","author":"Sourris","year":"2024","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2025.10.005_bib7","doi-asserted-by":"crossref","first-page":"233","DOI":"10.3390\/medicina55060233","article-title":"GLP-1 receptor agonists and kidney protection","volume":"55","author":"Greco","year":"2019","journal-title":"Medicina (Kaunas)"},{"key":"10.1016\/j.kint.2025.10.005_bib8","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.122.027712","article-title":"GLP-1 promotes cortical and medullary perfusion in the human kidney and maintains renal oxygenation during NaCl loading","volume":"12","author":"Haddock","year":"2023","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.kint.2025.10.005_bib9","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1210\/jc.2019-00004","article-title":"Extracellular fluid volume expansion uncovers a natriuretic action of GLP-1: a functional GLP-1-renal axis in man","volume":"104","author":"Asmar","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.kint.2025.10.005_bib10","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S2213-8587(18)30104-9","article-title":"Dulaglutide versus insulin glargine in patients with type 2 diabetes and moderate-to-severe chronic kidney disease (AWARD-7): a multicentre, open-label, randomised trial","volume":"6","author":"Tuttle","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.kint.2025.10.005_bib11","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1056\/NEJMoa2403347","article-title":"Effects of semaglutide on chronic kidney disease in patients with type 2 diabetes","volume":"391","author":"Perkovic","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.kint.2025.10.005_bib13","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1093\/ndt\/gfaf114","article-title":"Rationale, design and baseline characteristics of REMODEL, a mechanism-of-action trial with semaglutide in people with type 2 diabetes and chronic kidney disease","volume":"40","author":"Cherney","year":"2025","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2025.10.005_bib14","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s10334-019-00797-5","article-title":"Consensus-based technical recommendations for clinical translation of renal T1 and T2 mapping MRI","volume":"33","author":"Dekkers","year":"2020","journal-title":"MAGMA"},{"key":"10.1016\/j.kint.2025.10.005_bib15","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.kint.2022.10.023","article-title":"Precision nephrology identified tumor necrosis factor activation variability in minimal change disease and focal segmental glomerulosclerosis","volume":"103","author":"Mariani","year":"2023","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2025.10.005_bib16","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/s41586-023-05769-3","article-title":"An atlas of healthy and injured cell states and niches in the human kidney","volume":"619","author":"Lake","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.kint.2025.10.005_bib17","first-page":"667","article-title":"Blood oxygenation level-dependent MRI to assess renal oxygenation in renal diseases: progresses and challenges","volume":"7","author":"Pruijm","year":"2016","journal-title":"Front Physiol"},{"key":"10.1016\/j.kint.2025.10.005_bib18","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/j.kint.2017.10.020","article-title":"Reduced cortical oxygenation predicts a progressive decline of renal function in patients with chronic kidney disease","volume":"93","author":"Pruijm","year":"2018","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2025.10.005_bib19","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2024.1451671","article-title":"Effects of canagliflozin on kidney oxygenation evaluated using blood oxygenation level-dependent MRI in patients with type 2 diabetes","volume":"15","author":"Mori","year":"2024","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.kint.2025.10.005_bib20","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1148\/rg.2020190039","article-title":"Phase-contrast MRI: physics, techniques, and clinical applications","volume":"40","author":"Wymer","year":"2020","journal-title":"Radiographics"},{"key":"10.1016\/j.kint.2025.10.005_bib21","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1002\/jmri.27888","article-title":"Bias and precision in magnetic resonance imaging-based estimates of renal blood flow: assessment by triangulation","volume":"55","author":"Alhummiany","year":"2022","journal-title":"J Magn Reson Imaging"},{"key":"10.1016\/j.kint.2025.10.005_bib22","doi-asserted-by":"crossref","first-page":"ii4","DOI":"10.1093\/ndt\/gfy152","article-title":"Magnetic resonance imaging biomarkers for chronic kidney disease: a position paper from the European Cooperation in Science and Technology Action PARENCHIMA","volume":"33","author":"Selby","year":"2018","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2025.10.005_bib23","doi-asserted-by":"crossref","first-page":"3162","DOI":"10.1681\/ASN.2014080752","article-title":"Glomerular aging and focal global glomerulosclerosis: a podometric perspective","volume":"26","author":"Hodgin","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2025.10.005_bib24","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abn4965","article-title":"A reference tissue atlas for the human kidney","volume":"8","author":"Hansen","year":"2022","journal-title":"Sci Adv"},{"key":"10.1016\/j.kint.2025.10.005_bib25","article-title":"Single-nucleus transcriptomic analysis reveals important cell cross-talk in diabetic kidney disease","volume":"8","author":"Wei","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.kint.2025.10.005_bib26","doi-asserted-by":"crossref","DOI":"10.1172\/JCI164486","article-title":"SGLT2 inhibitors mitigate kidney tubular metabolic and mTORC1 perturbations in youth-onset type 2 diabetes","volume":"133","author":"Schaub","year":"2023","journal-title":"J Clin Invest"},{"key":"10.1016\/j.kint.2025.10.005_bib27","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s12864-025-11235-3","article-title":"A practical guide for choosing an optimal spatial transcriptomics technology from seven major commercially available options","volume":"26","author":"Lim","year":"2025","journal-title":"BMC Genomics"},{"key":"10.1016\/j.kint.2025.10.005_bib28","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ajpath.2024.06.011","article-title":"Histopathologic analysis of human kidney spatial transcriptomics data: toward precision pathology","volume":"195","author":"Isnard","year":"2025","journal-title":"Am J Pathol"},{"key":"10.1016\/j.kint.2025.10.005_bib29","doi-asserted-by":"crossref","first-page":"7010","DOI":"10.1038\/s41467-024-51186-z","article-title":"Spatial transcriptomics defines injury specific microenvironments and cellular interactions in kidney regeneration and disease","volume":"15","author":"Polonsky","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.kint.2025.10.005_bib30","article-title":"Principles of spatial transcriptomics analysis: a practical walk-through in kidney tissue","volume":"12","author":"Noel","year":"2021","journal-title":"Front Physiol"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253825008610?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253825008610?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T14:31:52Z","timestamp":1778941912000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253825008610"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S0085253825008610"],"URL":"https:\/\/doi.org\/10.1016\/j.kint.2025.10.005","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"REMODELing mechanistic trials for kidney disease: a multimodal, tissue-centered approach to understand the renal mechanism of action of semaglutide","name":"articletitle","label":"Article Title"},{"value":"Kidney International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.kint.2025.10.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 International Society of Nephrology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}